MCQ Screening For Gynea Cancers
MCQ Screening For Gynea Cancers
MCQ Screening For Gynea Cancers
5. What does a positive cytologic examination indicate in the context of vaginal cancer when
colposcopy and biopsy results are negative
A) No further action is needed.
B) The patient definitely has cancer.
C) There may still be a risk of cancer, and further monitoring is required.
D) Treatment should begin immediately.
E) A new cytology test is not necessary.
6. Which of the following statements is true regarding risk of developing cervical cancer?
A) Only women with a family history of cervical cancer are at risk.
B) Women who have never been sexually active are not at risk.
C) Women with regular Pap smears are not at risk for cervical cancer.
D) Cervical cancer only occurs in women over the age of 50.
E) All women are potentially at risk of developing cervical cancer at some point in their lifetime.
7. Which of the following statements about cervical cancer risk factors is true?
A) The most common risk factor for cervical cancer is being over the age of 50.
B) Early age of first intercourse and multiple sex partners are significant risk factors.
C) Cervical cancer only occurs in women who have had more than five sexual partners.
D) Women in their 20s are not at risk for cervical cancer at all.
E) Women between the ages of 30-50 are the only ones who can develop cervical cancer.
8. Which of the following statements about cervical cancer screening methods is true?
A) A Pap smear directly visualizes the cervix.
B) Colposcopy allows for a magnified view of the cervix and highlights abnormal blood vessels.
C) Endocervical curettage is primarily used for performing Pap smears.
D) Liquid-based cytology is not a method used for Pap smears.
E) Colposcopy does not involve the use of acetic acid.
10. What is the appropriate next step in the management plan when an abnormal cytology smear
shows a visible lesion but the biopsy is negative
a. Repeat the biopsy immediately.
b. Start treatment for invasive disease.
c. Perform a hysterectomy.
d. Do colposcopy and directed biopsy plus endocervical curettage (ECC).
e. Ignore and repeat cytology in 6 months
11. What is the recommended next step in management when there is no visible lesion?
a. Immediate treatment for invasive cancer.
b. Perform colposcopy and directed biopsy/ECC.
c. Repeat cytology in 12 months.
d. Administer HPV vaccination.
e. Perform a hysterectomy.
14. A patient has undergone a satisfactory negative colposcopy with a negative ECC. Based on
the provided guidelines, what is the appropriate management plan for this patient
A) Immediate LEEP excision regardless of findings.
B) Pap smear every 6 months, 3 or 4 times.
C) Cryotherapy or laser treatment immediately.
D) Pap smear plus HPV test every month.
E) No follow-up needed after a negative colposcopy.
15. What is the recommended management for a patient with an unsatisfactory colposcopy?
A) Repeat Pap smear in 6 months.
B) Cryotherapy.
C) Cone biopsy with ECC or deep LEEP with ECC.
D) Immediate hysterectomy.
E) HPV test and observation.
16. What is the recommended cervical cancer screening guideline for women aged 21–29
years?
A) Pap test every year with HPV testing.
B) No screening is needed for this age group.
C) HPV test alone every 3 years.
D) Pap test every 5 years with HPV testing.
E)Pap test alone every 3 years without HPV testing.
17. What is the preferred cervical cancer screening recommendation for women aged 30–65
years
A) Pap test alone every 5 years.
B) Pap test alone every 10 years.
C) HPV test alone every 3 years.
D) Pap test and HPV test (co-testing) every 5 years.
E) No screening needed.
18. When is it recommended to stop cervical cancer screening after age 65?
A) After two negative Pap test results in a row within the past 10 years.
B) After two negative co-test results in the past 15 years.
C) After one negative co-test result within the past 5 years.
D) After three negative Pap tests or two negative co-tests in the past 10 years, with the most
recent in the past 5 years.
E) After reaching 65, regardless of past results.
20.What is one of the ongoing approaches being evaluated in trials for ovarian cancer screening?
A) Annual screening with serum CA125
B) Annual screening with a Pap smear test.
C) Annual screening with only a transvaginal ultrasound.
D) Biannual screening with a CT scan.
E) Annual screening with a blood test for liver function.
1. C
2. A
3. C
4. B
5. C
6. E
7. B
8. B
9. E
10. D
11. B
12. C
13. B
14. B
15. C
16. E
17. D
18. D
19. C
20. A